Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04309565
NA

Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support

Sponsor: Yale University

View on ClinicalTrials.gov

Summary

TCN PATHS will recruit an anticipated 400 participants who are prescribed MOUD who are released from detention facilities. Each individual will be randomized to either 1) standard primary care (SPC) or 2) a Transitions Clinic Network (TCN) program primary care. Participants will be followed for a year and complete surveys at baseline and at month 1, 3, 6, 9, and 12. At each of these points research staff will confirm MOUD status. Urine drug screenings will be completed at baseline, month 1, 6, and 12 if the participant is not incarcerated. When possible, research staff will collect electronic health records.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

400

Start Date

2021-04-21

Completion Date

2025-12-30

Last Updated

2025-02-11

Healthy Volunteers

No

Interventions

BEHAVIORAL

Transitions Clinic Network Primary Care

Transitions Clinic Network (TCN)- participants in this arm will be referred to a TCN program for primary care and community Opioid Treatment Program (OTP). All TCN programs have the ability to prescribe buprenorphine and Extended-release naltrexone (XR-NTX) and assist with referrals to methadone. The primary features of the TCN include (1) primary care and onsite MOUD or referral to community treatment when indicated, (2) addressing social determinants of OUD and care coordination through a Community Health Worker (CHW), and (3) addressing the discrimination and stigma that exist based on incarceration.

BEHAVIORAL

Standard Primary Care

Those randomized to the standard primary care arm will be referred to primary care and community Opioid Treatment Program (OTP). Participants may receive buprenorphine or Extended-release naltrexone (XR-NTX) through primary care or with a community addiction treatment provider.

Locations (5)

Yale

New Haven, Connecticut, United States

Hennepin Healthcare

Minneapolis, Minnesota, United States

Albert Einstein College of Medicine

The Bronx, New York, United States

UNC Chapel Hill

Chapel Hill, North Carolina, United States

University of Puerto Rico

San Juan, Puerto Rico